Alderaan Biotechnology ALD2510 antibody shows promising tolerability and efficacy results for treatment of gynecologic and breast cancers.
En savoir plus
Atara Biotherapeutics, Inc. and Pierre Fabre today announced the CHMP of the EMA has adopted a positive opinion recommending the EC approval of EbvalloTM (tabelecleucel) as a monotherapy for treatment of adult and pediatric patients two years of age and older with relapsed or refractory Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD), who have received at least one prior therapy.
En savoir plus
Inotrem is an advanced clinical stage biotech company specialized in immunotherapy to control dysregulated inflammatory reactions.
En savoir plus
IMAVITA is an innovating contract research organization (CRO) proposing preclinical services in the exploration of preclinical models of human pathologies
En savoir plus
We are CMC experts in bioprocess industrialization, we provide strategy setting up & operational support from pre-clinical stages to product commercialization.
En savoir plus